Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May;35(Suppl 1):S180-S181.
doi: 10.5021/ad.21.225.

Bullous Wells Syndrome Induced by Ustekinumab

Yeona Kim  1   2   3 , Kyung-Nam Bae  1 , Jin-Hwa Son  1 , Kihyuk Shin  1   2 , Hoonsoo Kim  1   4 , Hyun-Chang Ko  1   2 , Byungsoo Kim  1   4 , Moon-Bum Kim  1   4   5
Affiliations

Bullous Wells Syndrome Induced by Ustekinumab

Yeona Kim et al. Ann Dermatol. 2023 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have nothing to disclose.

Figures

Fig. 1
Fig. 1. Erythematous swollen patches and bullae on the left arm (A) and leg (B).
Fig. 2
Fig. 2. (A) Sub- and intra-epidermal blisters with prominent dermal edema (H&E, ×20). (B) Dense inflammatory infiltration consisting mostly of eosinophils (H&E, ×200).
See this image and copyright information in PMC

References

    1. Wells GC. Recurrent granulomatous dermatitis with eosinophilia. Trans St Johns Hosp Dermatol Soc. 1971;57:46–56. - PubMed
    1. Heelan K, Ryan JF, Shear NH, Egan CA. Wells syndrome (eosinophilic cellulitis): proposed diagnostic criteria and a literature review of the drug-induced variant. J Dermatol Case Rep. 2013;7:113–120. - PMC - PubMed
    1. Aberer W, Konrad K, Wolff K. Wells’ syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Dermatol. 1988;18(1 Pt 1):105–114. - PubMed
    1. Rozenblat M, Cohen-Barak E, Dodiuk-Gad R, Ziv M. Wells’ syndrome induced by Ustekinumab. Isr Med Assoc J. 2019;21:65. - PubMed